Amneal Pharmaceuticals, Inc Class A Common Stock Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$784,513	$724,508	$695,420	$730,518
Gross Profit	273,974	286,253	255,891	262,873
EBITDA	111,664	176,925	154,584	112,473
EBIT	57,591	116,812	94,425	46,343
Net Income	2,369	22,417	12,195	-31,081
Net Change In Cash	784,513	724,508	695,420	730,518
Free Cash Flow	103,400	57,317	-10,914	95,014
Cash	201,249	81,186	59,187	110,552
Basic Shares	324,754	322,363	323,961	309,850

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$2,793,957	$2,393,607	$2,212,304	$2,093,669
Gross Profit	1,020,438	863,869	791,461	768,973
EBITDA	439,773	500,782	440,208	401,097
EBIT	203,582	271,382	200,033	167,691
Net Income	-116,886	-83,993	-129,985	10,624
Net Change In Cash	2,793,957	2,393,607	2,212,304	2,093,669
Cost of Revenue			-215,829	-90,484
Free Cash Flow	220,109	276,388	-25,495	194,092
Cash	110,552	91,542	25,976	247,790
Basic Shares	308,978	176,136	150,944	151,821